ArticleNanomedicine : nanotechnology, biology, and medicine2016

EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model.

Amit Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.